PLTP, the increased activity of which is known to be associated with atherosclerosis, systolic dysfunction, obesity, and diabetes (Chowaniec and Skoczyńska, 2018), was observed to be suppressed explicitly in all three IF groups. The gene discussed is PLTP; the disease is atherosclerosis.